New England Journal of Medicine
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Validation of a Rule for Termination of Resuscitation in Out-of-Hospital Cardiac Arrest
2006
-
Colchicine in Acute Myocardial Infarction.
2024
-
Routine Spironolactone in Acute Myocardial Infarction.
2024
-
Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia.
2024
-
Left Atrial Appendage Closure after Ablation for Atrial Fibrillation.
2024
-
Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer..
391:1413-1425.
2024
-
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B..
391:1108-1118.
2024
-
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage. Reply..
391:10.1056/NEJMc2407378#sa4.
2024
-
Liberal or Restrictive Transfusion Strategy in Patients with Traumatic Brain Injury.
391:722-735.
2024
-
Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A.
391:235-246.
2024
-
Stress Ulcer Prophylaxis during Invasive Mechanical Ventilation.
391:9-20.
2024
-
Andexanet for Factor Xa Inhibitor–Associated Acute Intracerebral Hemorrhage.
390:1745-1755.
2024
-
Antibody Fingerprints Linking Adenoviral Anti-PF4 Disorders.
390:1827-1829.
2024
-
Skin Antisepsis before Surgical Fracture Fixation.
390:1532-1533.
2024
-
Stroke Prevention in Subclinical Atrial Fibrillation.
390:1441-1442.
2024
-
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
390:911-921.
2024
-
An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis.
390:510-521.
2024
-
Skin Antisepsis before Surgical Fixation of Extremity Fractures.
390:409-420.
2024
-
Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure.
390:212-220.
2024
-
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.
390:107-117.
2024
-
Modifiable Risk Factors and Cardiovascular Outcomes.
389:2400-2402.
2023
-
Omitting Radiotherapy in Luminal A Breast Cancer.
389:1727-1728.
2023
-
Omitting Radiotherapy in Luminal A Breast Cancer..
389:1727.
2023
-
Coordinating Efforts to Reduce the Global Incidence of Cardiovascular Disease.
389:1329-1331.
2023
-
Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality.
389:1273-1285.
2023
-
Rescue Therapy in Chronic Prothrombotic Autoimmune Anti-PF4 Disorder.
389:1339-1341.
2023
-
Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer.
389:612-619.
2023
-
Duration of Adjunctive Antidepressant Maintenance in Bipolar I Depression.
389:430-440.
2023
-
Pegylated Interferon Lambda for Covid-19.
388:2107-2108.
2023
-
Dietary Sodium Restriction in Patients with Heart Failure.
388:1621-1623.
2023
-
Early Treatment with Pegylated Interferon Lambda for Covid-19.
388:518-528.
2023
-
Trial of an Intervention to Improve Acute Heart Failure Outcomes.
388:22-32.
2023
-
Choice of Admitting Services for Older Adults with Hip Fracture.
387:2466-2468.
2022
-
Ivermectin Treatment for Covid-19.
387:e66.
2022
-
Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation.
387:2100-2101.
2022
-
Teclistamab in Relapsed or Refractory Multiple Myeloma.
387:1721-1723.
2022
-
Teclistamab in Relapsed or Refractory Multiple Myeloma. Reply..
387:1722-1723.
2022
-
What Covid Has Taught the World about Ethics.
387:1542-1545.
2022
-
Pulmonary Embolism.
387:1241-1243.
2022
-
Pulmonary Embolism..
387:1241.
2022
-
A Randomized Trial of Enteral Glutamine for Treatment of Burn Injuries.
387:1001-1010.
2022
-
Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation.
387:978-988.
2022
-
Tranexamic Acid in Patients Undergoing Noncardiac Surgery.
387:858-859.
2022
-
Pulmonary Embolism.
387:45-57.
2022
-
Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit.
386:2387-2398.
2022
-
Troponin I after Cardiac Surgery and 30-Day Mortality.
386:2342-2343.
2022
-
Tranexamic Acid in Patients Undergoing Noncardiac Surgery.
386:1986-1997.
2022
-
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
386:1766-1768.
2022
-
Effect of Early Treatment with Ivermectin among Patients with Covid-19.
386:1721-1731.
2022
-
Mitapivat versus Placebo for Pyruvate Kinase Deficiency.
386:1432-1442.
2022
-
Molnupiravir for Covid-19 in Nonhospitalized Patients.
386:e32.
2022
-
Molnupiravir for Covid-19 in Nonhospitalized Patients..
386:e32.
2022
-
High-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality.
386:827-836.
2022
-
Abortion Safety and Use with Normally Prescribed Mifepristone in Canada.
386:57-67.
2022
-
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer.
385:2336-2347.
2021
-
Milvexian for the Prevention of Venous Thromboembolism.
385:2161-2172.
2021
-
Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes.
385:2105-2107.
2021
-
Abelacimab for Prevention of Venous Thromboembolism.
385:1821-1823.
2021
-
Risankizumab in Severe Asthma — A Phase 2a, Placebo-Controlled Trial.
385:1669-1679.
2021
-
Maintenance or Discontinuation of Antidepressants in Primary Care.
385:1257-1267.
2021
-
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke.
385:1053-1055.
2021
-
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.
385:896-907.
2021
-
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
385:777-789.
2021
-
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
385:790-802.
2021
-
Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia.
385:720-728.
2021
-
Abelacimab for Prevention of Venous Thromboembolism.
385:609-617.
2021
-
Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality.
385:378-380.
2021
-
Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
385:e11.
2021
-
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke.
384:2081-2091.
2021
-
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
384:2092-2101.
2021
-
Inhaled Treprostinil in Group 3 Pulmonary Hypertension.
384:1869-1872.
2021
-
Polypill in Persons without Cardiovascular Disease.
384:1673-1677.
2021
-
Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality.
384:1312-1322.
2021
-
Subcutaneous or Transvenous Defibrillator Therapy.
384:676-679.
2021
-
Resumption of Cardiac Activity after Withdrawal of Life-Sustaining Measures.
384:345-352.
2021
-
Polypill with or without Aspirin in Persons without Cardiovascular Disease.
384:216-228.
2021
-
Single or Dual Antiplatelet Treatment after TAVI.
384:89-91.
2021
-
Sodium Phenylbutyrate–Taurursodiol for ALS.
383:2293-2294.
2020
-
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.
383:2041-2052.
2020
-
Colchicine in Patients with Chronic Coronary Disease.
383:1838-1847.
2020
-
Colloid Transfusion, Natural Anticoagulant Depletion, and Symmetric Peripheral Gangrene.
383:1592-1594.
2020
-
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia.
383:617-629.
2020
-
Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.
383:240-251.
2020
-
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
382:2168-2169.
2020
-
Fair Allocation of Scarce Medical Resources in the Time of Covid-19.
382:2049-2055.
2020
-
Rivaroxaban in Peripheral Artery Disease after Revascularization.
382:1994-2004.
2020
-
Complete Revascularization with Multivessel PCI for Myocardial Infarction.
382:1568-1572.
2020
-
Diagnosis of Pulmonary Embolism with
d
-Dimer Testing.
382:1074-1075.
2020
-
Diagnosis of Pulmonary Embolism with d-Dimer Testing..
382:1074.
2020
-
Diagnosis of Pulmonary Embolism with d-Dimer Testing..
382:1074-1075.
2020
-
Total Hip Arthroplasty or Hemiarthroplasty for Hip Fracture.
382:1072-1074.
2020
-
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
382:622-631.
2020
-
Organ Donation after Medical Assistance in Dying — Canada’s First Cases.
382:576-577.
2020
-
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC.
382:41-50.
2020
-
Total Hip Arthroplasty or Hemiarthroplasty for Hip Fracture.
381:2199-2208.
2019
-
Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability.
381:2125-2134.
2019
-
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
381:1718-1727.
2019
-
Complete Revascularization with Multivessel PCI for Myocardial Infarction.
381:1411-1421.
2019
-
Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer.
381:1289-1291.
2019
-
Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer..
381:1289-1291.
2019
-
Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer. Reply..
381:1290-1291.
2019
-
Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers.
381:585-586.
2019
-
Application of High-Sensitivity Troponin in Suspected Myocardial Infarction.
380:2529-2540.
2019
-
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.
380:2395-2405.
2019
-
Aspiration Pneumonia.
380:e40-e40.
2019
-
Aspiration Pneumonia Reply.
380.
2019
-
Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers.
380:1825-1833.
2019
-
The RACE to Treat Atrial Fibrillation in the Emergency Department.
380:1578-1579.
2019
-
A Device on Trial — Intermittent Pneumatic Compression in Critical Care.
380:1367-1368.
2019
-
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors.
380:1326-1335.
2019
-
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer.
380:711-719.
2019
-
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.
380:720-728.
2019
-
Aspiration Pneumonia.
380:651-663.
2019
-
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
380:45-56.
2019
-
Restrictive versus Liberal Transfusion for Cardiac Surgery.
379:2575-2577.
2018
-
Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016.
379:2429-2437.
2018
-
Men’s Fear of Mentoring in the #MeToo Era — What’s at Stake for Academic Medicine?.
379:2270-2274.
2018
-
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.
379:2097-2107.
2018
-
Multicenter Trial of a Combination Probiotic for Children with Gastroenteritis.
379:2015-2026.
2018
-
Radial-Artery Grafts for Coronary-Artery Bypass Surgery.
379:1966-1968.
2018
-
Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis.
379:1722-1731.
2018
-
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease (vol 374, pg 2032, 2016).
379:1486-1486.
2018
-
Six-Month Outcomes after Restrictive or Liberal Transfusion for Cardiac Surgery.
379:1224-1233.
2018
-
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.
379:1118-1127.
2018
-
Vitamin D Supplementation in Pregnancy and Lactation and Infant Growth.
379:535-546.
2018
-
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
379:111-121.
2018
-
Combined Analysis of Asthma Safety Trials of Long-Acting β2-Agonists.
378:2497-2505.
2018
-
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma.
378:2475-2485.
2018
-
Prophylaxis against Upper Gastrointestinal Bleeding in Hospitalized Patients.
378:2506-2516.
2018
-
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
378:2191-2201.
2018
-
As-Needed Budesonide–Formoterol versus Maintenance Budesonide in Mild Asthma.
378:1877-1887.
2018
-
Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma.
378:1865-1876.
2018
-
Intravenous Immune Globulin to Prevent Heparin-Induced Thrombocytopenia.
378:1845-1848.
2018
-
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty.
378:699-707.
2018
-
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.
378:615-624.
2018
-
Edoxaban for the Treatment of Venous Thromboembolism in Patients with Cancer.
378:673-674.
2018
-
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy.
378:625-635.
2018
-
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.
378:345-353.
2018
-
Rivaroxaban in Stable Cardiovascular Disease.
378:395-398.
2018
-
TO THE EDITOR REPLY.
378:397-+.
2018
-
Osimertinib in UntreatedEGFR-Mutated Advanced Non–Small-Cell Lung Cancer.
378:113-125.
2018
-
Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis.
377:2240-2252.
2017
-
Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery.
377:2133-2144.
2017
-
Management of Acute Hip Fracture.
377:2053-2062.
2017
-
Dabigatran Reversal with Idarucizumab.
377:1690-1692.
2017
-
Dabigatran Reversal with Idarucizumab..
377:1691-1692.
2017
-
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.
377:1319-1330.
2017
-
Glucocorticoid Sparing of Benralizumab in Asthma.
377:1204-1205.
2017
-
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
377:723-732.
2017
-
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis.
377:431-441.
2017
-
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist.
377:28-40.
2017
-
Extended Treatment of Venous Thromboembolism.
376:2491-2492.
2017
-
Extended Treatment of Venous Thromboembolism REPLY.
376:2492-2492.
2017
-
First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer.
376:2415-2426.
2017
-
Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma.
376:2448-2458.
2017
-
Targeting Eosinophils in Eosinophilic Granulomatosis with Polyangiitis.
376:1985-1986.
2017
-
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
376:1527-1539.
2017
-
Reduced-Intensity Rivaroxaban for the Prevention of Recurrent Venous Thromboembolism.
376:1279-1280.
2017
-
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.
376:1211-1222.
2017
-
Geographic Variations in Controlled Trials.
376:1196-1198.
2017
-
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor.
376:1131-1140.
2017
-
Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Disease.
376:1087-1089.
2017
-
Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma.
376:1027-1037.
2017
-
Short-Term versus Long-Term Blood Storage.
376:1091-1094.
2017
-
Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting.
376:894-895.
2017
-
Thromboprophylaxis after Knee Arthroscopy.
376:580-583.
2017
-
Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.
376:417-428.
2017
-
Andexanet Alfa for Factor Xa Inhibitor Reversal.
375:2498-2500.
2016
-
Atrial Fibrillation and PCI — Do We Still Need Aspirin?.
375:2490-2492.
2016
-
Dietary Sodium and Cardiovascular Disease Risk.
375:2404-2408.
2016
-
Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting.
375:2359-2368.
2016
-
Interpreting Geographic Variations in Results of Randomized, Controlled Trials.
375:2263-2271.
2016
-
Effect of Short-Term vs. Long-Term Blood Storage on Mortality after Transfusion.
375:1937-1945.
2016
-
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease.
375:1946-1960.
2016
-
Romosozumab Treatment in Postmenopausal Women with Osteoporosis.
375:1532-1543.
2016
-
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors.
375:1131-1141.
2016
-
Blood-Pressure and Cholesterol Lowering in the HOPE-3 Trial.
375:1190-1194.
2016
-
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients.
375:534-544.
2016
-
Toward Fairness in Data Sharing.
375:405-407.
2016
-
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.
375:209-219.
2016
-
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
375:111-121.
2016
-
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.
374:2009-2020.
2016
-
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.
374:2032-2043.
2016
-
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.
374:2021-2031.
2016
-
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate.
374:2093-2095.
2016
-
Postmenopausal Osteoporosis.
374:2095-2097.
2016
-
One-Year Outcomes in Caregivers of Critically Ill Patients.
374:1831-1841.
2016
-
Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.
374:1711-1722.
2016
-
Wound Irrigation in Initial Management of Open Fractures.
374:1788-1790.
2016
-
Cardiac Complications and Major Noncardiac Surgery.
374:1393-1395.
2016
-
A Multicenter Observational Study of Incretin-based Drugs and Heart Failure.
374:1145-1154.
2016
-
Subclinical Atrial Fibrillation and the Risk of Stroke (vol 366, pg 120, 2012).
374:998-998.
2016
-
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate.
374:411-421.
2016
-
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.
374:135-145.
2016
-
Bridging Anticoagulation in Patients with Atrial Fibrillation.
374:90-94.
2016
-
A Trial of Wound Irrigation in the Initial Management of Open Fracture Wounds.
373:2629-2641.
2015
-
Selexipag for the Treatment of Pulmonary Arterial Hypertension.
373:2522-2533.
2015
-
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity.
373:2413-2424.
2015
-
Ischemic Limb Gangrene with Pulses.
373:2385-2388.
2015
-
Cardiac Complications in Patients Undergoing Major Noncardiac Surgery.
373:2258-2269.
2015
-
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
373:2247-2257.
2015
-
Trial of Continuous or Interrupted Chest Compressions during CPR.
373:2203-2214.
2015
-
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.
373:2005-2014.
2015
-
Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease.
373:1937-1946.
2015
-
Troponin in Stable Ischemic Heart Disease and Diabetes.
373:1976-1977.
2015
-
Troponin in Stable Ischemic Heart Disease and Diabetes.
373:1976-1979.
2015
-
Troponin in Stable Ischemic Heart Disease and Diabetes..
373:1976.
2015
-
Troponin in Stable Ischemic Heart Disease and Diabetes..
373:1977.
2015
-
Troponin in Stable Ischemic Heart Disease and Diabetes..
373:1977-1978.
2015
-
Troponin in Stable Ischemic Heart Disease and Diabetes..
373:1978-1979.
2015
-
Regional Nodal Irradiation in Early-Stage Breast Cancer.
373:1877-1880.
2015
-
Regional Nodal Irradiation in Early-Stage Breast Cancer..
373:1878.
2015
-
Regional Nodal Irradiation in Early-Stage Breast Cancer..
373:1877-1878.
2015
-
Regional Nodal Irradiation in Early-Stage Breast Cancer..
373:1879-1880.
2015
-
High-Flow Nasal Cannula Oxygen in Respiratory Failure.
373:1373-1375.
2015
-
Randomized Trial of Benznidazole for Chronic Chagas’ Cardiomyopathy.
373:1295-1306.
2015
-
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation.
373:823-833.
2015
-
Screening for Occult Cancer in Unprovoked Venous Thromboembolism.
373:697-704.
2015
-
Ischemic Limb Gangrene with Pulses.
373:642-655.
2015
-
Primary PCI with or without Thrombectomy.
373:680-683.
2015
-
Idarucizumab for Dabigatran Reversal.
373:511-520.
2015
-
Regional Nodal Irradiation in Early-Stage Breast Cancer.
373:307-316.
2015
-
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
373:232-242.
2015
-
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
372:2387-2397.
2015
-
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction.
372:1791-1800.
2015
-
Preexposure Prophylaxis for HIV Infection.
372:1767-1768.
2015
-
Factor XI Antisense Oligonucleotide for Venous Thrombosis.
372:1671-1672.
2015
-
Genetically Determined Height and Coronary Artery Disease.
372:1608-1618.
2015
-
Age of Transfused Blood in Critically Ill Adults.
372:1410-1418.
2015
-
Gestational Hypertension and Preeclampsia in Living Kidney Donors.
372:1468-1470.
2015
-
Randomized Trial of Primary PCI with or without Routine Manual Thrombectomy.
372:1389-1398.
2015
-
The Concept of Risk in Comparative Effectiveness Research.
372:883-884.
2015
-
Driving Pressure and Survival in the Acute Respiratory Distress Syndrome.
372:747-755.
2015
-
Asthma and Exercise-Induced Bronchoconstriction in Athletes.
372:641-648.
2015
-
Heparin-Induced Thrombocytopenia Presenting as Bilateral Adrenal Hemorrhages.
372:492-494.
2015
-
Less-Tight versus Tight Control of Hypertension in Pregnancy.
372:407-417.
2015
-
Cardiovascular Risk and Events and Country Income Stratum.
372:288-290.
2015
-
Community-Acquired Pneumonia.
372:292-294.
2015
-
Community-Acquired Pneumonia.
372:293-294.
2015
-
Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis.
372:232-240.
2015
-
Intracranial Arteriovenous Malformation.
372:e4-e4.
2015
-
Gestational Hypertension and Preeclampsia in Living Kidney Donors.
372:124-133.
2015
-
Immunotherapy for Tuberculous Pericarditis.
371:2531-2535.
2014
-
Sodium and Cardiovascular Disease.
371:2135-2136.
2014
-
Sodium and Cardiovascular Disease.
371:2134-2139.
2014
-
Sodium and cardiovascular disease..
371:2137.
2014
-
Sodium and cardiovascular disease..
371:2134.
2014
-
Sodium and cardiovascular disease..
371:2134-2135.
2014
-
Sodium and cardiovascular disease..
371:2135-2136.
2014
-
Sodium and cardiovascular disease..
371:2136-2137.
2014
-
Sodium and cardiovascular disease..
371:2138-2139.
2014
-
The Route of Early Nutrition in Critical Illness.
371:1748-1749.
2014
-
Additional Events in the RE-LY Trial.
371:1464-1465.
2014
-
Anti–Interleukin-5 Monoclonal Antibody to Treat Severe Eosinophilic Asthma.
371:1249-1251.
2014
-
Cryptogenic Stroke and Atrial Fibrillation.
371:1259-1262.
2014
-
Cryptogenic stroke and atrial fibrillation..
371:1260.
2014
-
Prednisolone andMycobacterium indicus praniiin Tuberculous Pericarditis.
371:1121-1130.
2014
-
Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries.
371:818-827.
2014
-
Association of Urinary Sodium and Potassium Excretion with Blood Pressure.
371:601-611.
2014
-
Urinary Sodium and Potassium Excretion, Mortality, and Cardiovascular Events.
371:612-623.
2014
-
Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials.
371:326-338.
2014
-
The mTORC Pathway in the Antiphospholipid Syndrome.
371:369-371.
2014
-
Atrial Fibrillation in Patients with Cryptogenic Stroke.
370:2467-2477.
2014
-
Dying with Dignity in the Intensive Care Unit.
370:2506-2514.
2014
-
Hemicraniectomy for Middle-Cerebral-Artery Stroke.
370:2346-2348.
2014
-
Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses.
370:2102-2110.
2014
-
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis.
370:2071-2082.
2014
-
ERCP for Gallstone Pancreatitis.
370:1954-1956.
2014
-
Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease.
370:1702-1711.
2014
-
Aspirin in Patients Undergoing Noncardiac Surgery.
370:1494-1503.
2014
-
Clonidine in Patients Undergoing Noncardiac Surgery.
370:1504-1513.
2014
-
Dabigatran in Patients with Mechanical Heart Valves.
370:381-384.
2014
-
Second-Pandemic Strain ofVibrio choleraefrom the Philadelphia Cholera Outbreak of 1849.
370:334-340.
2014
-
Preventive Angioplasty in Myocardial Infarction.
370:280-283.
2014
-
Edoxaban versus Warfarin in Patients with Atrial Fibrillation.
369:2093-2104.
2013
-
When It Comes to Trials, Do We Get What We Pay For?.
369:1962-1963.
2013
-
Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma.
369:1681-1690.
2013
-
Hospitalizations after a Decade of Pneumococcal Vaccination.
369:1662-1663.
2013
-
Device Surgery without Interruption of Anticoagulation.
369:1570-1572.
2013
-
Device surgery without interruption of anticoagulation..
369:1570-1571.
2013
-
A Randomized Trial of Planned Cesarean or Vaginal Delivery for Twin Pregnancy.
369:1295-1305.
2013
-
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes.
369:1327-1335.
2013
-
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus.
369:1317-1326.
2013
-
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves.
369:1206-1214.
2013
-
Antithrombotic Therapy and Invasive Procedures.
369:1077-1080.
2013
-
Randomized Clinical Trials — Removing Unnecessary Obstacles.
369:1061-1065.
2013
-
Probability of Cancer in Pulmonary Nodules Detected on First Screening CT.
369:910-919.
2013
-
Oral Apixaban for the Treatment of Acute Venous Thromboembolism.
369:799-808.
2013
-
A Trial Comparing Noninvasive Ventilation Strategies in Preterm Infants.
369:611-620.
2013
-
Do Lifestyle Changes Reduce Serious Outcomes in Diabetes?.
369:189-190.
2013
-
Off-Pump or On-Pump Coronary-Artery Bypass Grafting.
369:194-197.
2013
-
Off-pump or on-pump coronary-artery bypass grafting..
369:194.
2013
-
Off-pump or on-pump coronary-artery bypass grafting..
369:195.
2013
-
Off-pump or on-pump coronary-artery bypass grafting..
369:194.
2013
-
Off-pump or on-pump coronary-artery bypass grafting..
369:197.
2013
-
Off-pump or on-pump coronary-artery bypass grafting..
369:194-195.
2013
-
Off-pump or on-pump coronary-artery bypass grafting..
369:195-196.
2013
-
Off-pump or on-pump coronary-artery bypass grafting..
369:196-197.
2013
-
Extended Anticoagulation in Venous Thromboembolism.
368:2328-2329.
2013
-
Extended anticoagulation in venous thromboembolism..
368:2329.
2013
-
Extended anticoagulation in venous thromboembolism..
368:2329.
2013
-
Extended anticoagulation in venous thromboembolism..
368:2328-2329.
2013
-
High-Frequency Oscillation for ARDS.
368:2231-2234.
2013
-
Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation.
368:2084-2093.
2013
-
Pooled Platelet Concentrates or Apheresis Platelets?.
368:1848-1849.
2013
-
A Randomized Trial of Glutamine and Antioxidants in Critically Ill Patients.
368:1489-1497.
2013
-
Factor VIII Products and Inhibitors in Severe Hemophilia A.
368:1456-1457.
2013
-
Factor VIII Products and Inhibitors in Severe Hemophilia A REPLY.
368:1457-1457.
2013
-
Factor VIII products and inhibitors in severe hemophilia A..
368:1456.
2013
-
Effects of Off-Pump and On-Pump Coronary-Artery Bypass Grafting at 1 Year.
368:1179-1188.
2013
-
High-Frequency Oscillation in Early Acute Respiratory Distress Syndrome.
368:795-805.
2013
-
Apixaban for Extended Treatment of Venous Thromboembolism.
368:699-708.
2013
-
Aspirin for Preventing Venous Thromboembolism.
368:772-773.
2013
-
Aspirin for preventing venous thromboembolism..
368:772.
2013
-
Aspirin for preventing venous thromboembolism..
368:773.
2013
-
Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism.
368:709-718.
2013
-
Nonheparin Anticoagulants for Heparin-Induced Thrombocytopenia.
368:737-744.
2013
-
Peripheral Mechanisms in Irritable Bowel Syndrome.
368:577-579.
2013
-
Peripheral mechanisms in irritable bowel syndrome..
368:578.
2013
-
Peripheral mechanisms in irritable bowel syndrome..
368:577-578.
2013
-
Peripheral mechanisms in irritable bowel syndrome..
368:578-579.
2013
-
Donor Exposures in Recipients of Pooled Platelet Concentrates.
368:487-489.
2013
-
Proteotoxicity and Cardiac Dysfunction — Alzheimer's Disease of the Heart?.
368:455-464.
2013
-
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy.
368:138-148.
2013
-
The authors reply.
368:1849.
2013
-
Aspirin for Dual Prevention of Venous and Arterial Thrombosis.
367:2039-2041.
2012
-
Intensive Care in Low-Income Countries — A Critical Need.
367:1974-1976.
2012
-
Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism.
367:1979-1987.
2012
-
Basal Insulin and Cardiovascular and Other Outcomes.
367:1761-1764.
2012
-
Basal insulin and cardiovascular and other outcomes..
367:1763.
2012
-
n-3 Fatty Acids and Cardiovascular Outcomes in Dysglycemia.
367:1761-1761.
2012
-
n–3 Fatty Acids and Cardiovascular Outcomes in Dysglycemia.
367:1760-1761.
2012
-
Hypoglycemia and Risk of Death in Critically Ill Patients.
367:1108-1118.
2012
-
Guillain–Barré Syndrome.
367:973-974.
2012
-
Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy.
367:895-903.
2012
-
Acute Hepatic Necrosis and Ischemic Limb Necrosis.
367:879-881.
2012
-
Off-Pump or On-Pump Coronary-Artery Bypass Grafting.
367:577-578.
2012
-
Off-Pump or On-Pump Coronary-Artery Bypass Grafting REPLY.
367:578-578.
2012
-
Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia.
367:319-328.
2012
-
n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia.
367:309-318.
2012
-
Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm.
366:1859-1869.
2012
-
Warfarin in Heart Failure.
366:1936-1938.
2012
-
Thromboprophylaxis in Patients Receiving Chemotherapy.
366:1839-1840.
2012
-
Bone-Density Testing Interval and Transition to Osteoporosis.
366:1546-1548.
2012
-
Iron Overload in Human Disease.
366:1548-1550.
2012
-
Off-Pump or On-Pump Coronary-Artery Bypass Grafting at 30 Days.
366:1489-1497.
2012
-
Vorapaxar in the Secondary Prevention of Atherothrombotic Events.
366:1404-1413.
2012
-
HIV and Aging — Preparing for the Challenges Ahead.
366:1270-1273.
2012
-
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism.
366:1287-1297.
2012
-
Subclinical Atrial Fibrillation and the Risk of Stroke REPLY.
366:1352-1353.
2012
-
The authors reply.
366:1352-1353.
2012
-
More on Acutely Injured Patients Receiving Dabigatran.
366:863-864.
2012
-
Apixaban versus Enoxaparin in Medically Ill Patients.
366:767-768.
2012
-
Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer.
366:601-609.
2012
-
ABVD Alone versus Radiation-Based Therapy in Limited-Stage Hodgkin's Lymphoma.
366:399-408.
2012
-
Subclinical Atrial Fibrillation and the Risk of Stroke.
366:120-129.
2012
-
Routine heparin for patients with cancer? One answer, more questions.
366:661-2.
2012
-
Dronedarone in High-Risk Permanent Atrial Fibrillation.
365:2268-2276.
2011
-
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy.
365:2255-2267.
2011
-
Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients.
365:2167-2177.
2011
-
A Novel Sickling Hemoglobinopathy.
365:1548-1549.
2011
-
SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts.
365:1384-1395.
2011
-
Dalteparin and Heparin-Induced Thrombocytopenia.
365:1158-1158.
2011
-
Thrombopoietin-Receptor Agonists for Primary Immune Thrombocytopenia.
365:734-741.
2011
-
Leukotriene Antagonists in Asthma.
365:272-274.
2011
-
Dalteparin in Critically Ill Patients REPLY.
365:180-180.
2011
-
The author replies.
365:180.
2011
-
Apixaban in Patients with Atrial Fibrillation REPLY.
364:2363-2364.
2011
-
The authors reply.
364:2363-2364.
2011
-
Intensive Glucose Lowering and Cardiovascular Outcomes REPLY.
364:2264-2264.
2011
-
Long-Acting Risperidone and Oral Antipsychotics in Schizophrenia.
364:2264-2266.
2011
-
Leukotriene Antagonists as First-Line or Add-on Asthma-Controller Therapy.
364:1695-1707.
2011
-
Treatment of Acute Otitis Media in Children.
364:1775-1779.
2011
-
Treatment of acute otitis media in children..
364:1777.
2011
-
Dalteparin versus Unfractionated Heparin in Critically Ill Patients.
364:1305-1314.
2011
-
Functional Disability 5 Years after Acute Respiratory Distress Syndrome.
364:1293-1304.
2011
-
Irbesartan in Patients with Atrial Fibrillation.
364:928-938.
2011
-
Apixaban in Patients with Atrial Fibrillation.
364:806-817.
2011
-
Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes.
364:818-828.
2011
-
CYP2C19 Genotype and Outcomes of Clopidogrel Treatment REPLY.
364:482-482.
2011
-
Endometriosis-Associated Ovarian Carcinomas.
364:482-485.
2011
-
Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement.
363:2487-2498.
2010
-
Oral Rivaroxaban for Symptomatic Venous Thromboembolism.
363:2499-2510.
2010
-
Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure.
363:2385-2395.
2010
-
Dosing of Clopidogrel and Aspirin in Acute Coronary Syndromes REPLY.
363:2467-2468.
2010
-
The authors reply.
363:2467-2468.
2010
-
Newly Identified Events in the RE-LY Trial.
363:1875-1876.
2010
-
Effects ofCYP2C19Genotype on Outcomes of Clopidogrel Treatment.
363:1704-1714.
2010
-
Fondaparinux for the Treatment of Superficial-Vein Thrombosis in the Legs.
363:1222-1232.
2010
-
Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes.
363:930-942.
2010
-
Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes.
363:233-244.
2010
-
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis.
363:211-220.
2010
-
Target Ranges of Oxygen Saturation in Extremely Preterm Infants.
362:1959-1969.
2010
-
Hypofractionated Radiotherapy for Breast Cancer.
362:1843-1844.
2010
-
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus (vol 362, pg 1563, 2010).
362:1748-1748.
2010
-
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus.
362:1563-1574.
2010
-
Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus.
362:1575-1585.
2010
-
Dabigatran versus Warfarin for Venous Thromboembolism.
362:1050-1051.
2010
-
Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer.
362:513-520.
2010
-
Vanishing Mediastinal Mass.
361:2653-2653.
2009
-
Sensitive Cardiac Troponin Assays.
361:2575-2577.
2009
-
Sensitive cardiac troponin assays..
361:2575.
2009
-
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism.
361:2342-2352.
2009
-
Accuracy of Conflict-of-Interest Disclosures Reported by Physicians.
361:1466-1474.
2009
-
Clopidogrel plus aspirin in atrial fibrillation..
361:1314.
2009
-
The authors reply.
361:1314-1315.
2009
-
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
361:1139-1151.
2009
-
Acute Coronary Syndromes REPLY.
361:926-927.
2009
-
The authors reply.
361:926-927.
2009
-
Long-Acting Beta-Agonists in Asthma REPLY.
361:209-209.
2009
-
Prescribing Records and the First Amendment.
361:209-210.
2009
-
Routine Early Angioplasty after Fibrinolysis for Acute Myocardial Infarction.
360:2705-2718.
2009
-
Anti-Interleukin-5 Therapy and Severe Asthma REPLY.
360:2577-2577.
2009
-
Dr. Nair and colleagues reply.
360:2577.
2009
-
Early versus Delayed Invasive Intervention in Acute Coronary Syndromes.
360:2165-2175.
2009
-
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation.
360:2066-2078.
2009
-
Risks of Long-Acting Beta-Agonists in Achieving Asthma Control.
360:1671-1672.
2009
-
Intensive versus Conventional Glucose Control in Critically Ill Patients.
360:1283-1297.
2009
-
Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia.
360:985-993.
2009
-
Telmisartan for Prevention of Cardiovascular Events Reply.
360:303-303.
2009
-
The authors reply.
360:303.
2009
-
Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction.
359:2456-2467.
2008
-
Dr. Lassen and colleagues reply.
359:2175-2176.
2008
-
Rivaroxaban for Thromboprophylaxis Reply.
359:2175-2176.
2008
-
Dr. Byington and colleagues reply.
359:1520-1521.
2008
-
Intensive glucose control in type 2 diabetes - Reply.
359:1520-1521.
2008
-
Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke.
359:1238-1251.
2008
-
Contaminated Heparin.
359:1291-1293.
2008
-
Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events.
359:1225-1237.
2008
-
Life and Death after ICD Implantation.
359:1058-1059.
2008
-
Effect of PCI on Quality of Life in Patients with Stable Coronary Disease.
359:677-687.
2008
-
Multiple Tumors in a Child with Germ-Line Mutations inTP53andPTEN.
359:537-539.
2008
-
Violence-related mortality in Iraq, 2002-2006..
359:432.
2008
-
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty.
358:2776-2786.
2008
-
Effects of Intensive Glucose Lowering in Type 2 Diabetes.
358:2545-2559.
2008
-
Hypothermia Therapy after Traumatic Brain Injury in Children.
358:2447-2456.
2008
-
Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events.
358:1547-1559.
2008
-
Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock.
358:877-887.
2008
-
Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer.
358:641-644.
2008
-
Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer - Reply.
358:643-643.
2008
-
Long-Term Effects of Caffeine Therapy for Apnea of Prematurity.
357:1893-1902.
2007
-
Appropriate medical management and close follow-up for adherence and efficacy.
357:1763.
2007
-
Clinical decisions. Management of stable coronary disease..
357:1762-1766.
2007
-
Management of Stable Coronary Disease.
357:1762-1766.
2007
-
Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer.
357:1579-1588.
2007
-
Effectiveness and Safety of Drug-Eluting Stents in Ontario.
357:1393-1402.
2007
-
Surgical versus Nonsurgical Treatment for Back Pain.
357:1255-1256.
2007
-
Targeting Anemia with Erythropoietin during Critical Illness.
357:1037-1039.
2007
-
PCI for stable coronary disease - Reply.
357:417-418.
2007
-
Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease.
357:217-227.
2007
-
Preimplantation Genetic Screening in Older Mothers.
357:61-63.
2007
-
Redarkening of Port-Wine Stains 10 Years after Laser Treatment.
356:2745-2746.
2007
-
Heparin-Induced Thrombocytopenia Associated with Fondaparinux.
356:2653-2655.
2007
-
Advanced Life Support for Out-of-Hospital Respiratory Distress.
356:2156-2164.
2007
-
Optimal Medical Therapy with or without PCI for Stable Coronary Disease.
356:1503-1516.
2007
-
Diagnosis of ventilator-associated pneumonia - Reply.
356:1470-1471.
2007
-
The authors reply [4].
356:1470-1471.
2007
-
Asthma Control during the Year after Bronchial Thermoplasty.
356:1327-1337.
2007
-
Treatment of Restenosis with a Paclitaxel-Coated Balloon Catheter.
356:1071-1073.
2007
-
Drug-Induced Immune-Mediated Thrombocytopenia — From Purpura to Thrombosis.
356:891-893.
2007
-
Effect of ramipril on the incidence of diabetes - Reply.
356:523-524.
2007
-
The authors reply [6].
356:523-524.
2007
-
Chronic Prostatitis.
356:423-424.
2007
-
A Randomized Trial of Diagnostic Techniques for Ventilator-Associated Pneumonia.
355:2619-2630.
2006
-
Building on Experience — The Development of Clinical Reasoning.
355:2251-2252.
2006
-
Case records of the Massachusetts General Hospital. Case 34-2006. A 72-year-old woman with nausea followed by hypotension and respiratory failure..
355:2022-2031.
2006
-
Adjuvant Chemotherapy for Breast Cancer — 30 Years Later.
355:1920-1922.
2006
-
d-Dimer Testing to Determine the Duration of Anticoagulation Therapy.
355:1780-1789.
2006
-
Effect of Ramipril on the Incidence of Diabetes.
355:1551-1562.
2006
-
Caffeine for apnea of prematurity - Reply.
355:959-960.
2006
-
The authors reply [10].
355:959-960.
2006
-
Anthracyclines in Early Breast Cancer.
355:845-846.
2006
-
Doppler Ultrasonography versus Amniocentesis to Predict Fetal Anemia.
355:156-164.
2006
-
Homocysteine, B vitamins, and cardiovascular disease - Reply.
355:209-210.
2006
-
Enoxaparin versus Unfractionated Heparin in ST-Elevation Myocardial Infarction.
354:2830-2832.
2006
-
Fondaparinux versus enoxaparin in acute coronary syndromes - Reply.
354:2830-2830.
2006
-
HER2and Responsiveness of Breast Cancer to Adjuvant Chemotherapy.
354:2103-2111.
2006
-
Caffeine Therapy for Apnea of Prematurity.
354:2112-2121.
2006
-
Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events.
354:1706-1717.
2006
-
Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease.
354:1567-1577.
2006
-
Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes.
354:1464-1476.
2006
-
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck.
354:567-578.
2006
-
Genetic Modifiers of Lung Disease in Cystic Fibrosis.
353:1443-1453.
2005
-
The VA and Medicare HMOs — Complementary or Redundant?.
353:1302-1303.
2005
-
Lipid-Lowering Therapy in Calcific Aortic Stenosis.
353:1066-1067.
2005
-
Multidetector-Row Computed Tomography in Suspected Pulmonary Embolism.
353:630-631.
2005
-
Thrombosis of the Cerebral Veins and Sinuses.
353:314-315.
2005
-
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome.
353:133-144.
2005
-
Avian Influenza and Pandemics.
352:1928-1928.
2005
-
Remission of Macroglobulinemia during Anastrozole Treatment for Breast Cancer.
352:1725-1726.
2005
-
Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation.
352:1179-1189.
2005
-
ACE Inhibition in Stable Coronary Artery Disease.
352:937-939.
2005
-
Prophylactic Use of an Implantable Cardioverter–Defibrillator after Acute Myocardial Infarction.
351:2481-2488.
2004
-
Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery Disease.
351:2058-2068.
2004
-
Deep-Vein Thrombosis.
351:2133-2134.
2004
-
Fluid Resuscitation in the Intensive Care Unit.
351:1905-1908.
2004
-
Fluid resuscitation in the intensive care unit - The editorialist replies.
351:1908-1908.
2004
-
Treatment of Deep-Vein Thrombosis.
351:268-277.
2004
-
The Effect of Dexrazoxane on Myocardial Injury in Doxorubicin-Treated Children with Acute Lymphoblastic Leukemia.
351:145-153.
2004
-
Is Albumin Safe?.
350:2294-2296.
2004
-
A Comparison of Laparoscopically Assisted and Open Colectomy for Colon Cancer.
350:2050-2059.
2004
-
Ximelagatran for Secondary Prevention of Venous Thromboembolism.
350:618-619.
2004
-
Long-Term Follow-up of Asthma.
350:304-304.
2004
-
Long-term follow-up of asthma - The authors reply.
350:304-304.
2004
-
A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome.
349:2577-2577.
2003
-
Warfarin Prophylaxis in the Antiphospholipid Antibody Syndrome.
349:2568-2570.
2003
-
Warfarin prophylaxis in the antiphospholipid antibody syndrome - Reply.
349:2569-2570.
2003
-
Withdrawal of Mechanical Ventilation.
349:2565-2567.
2003
-
Withdrawal of mechanical ventilation - Reply.
349:2566-2567.
2003
-
Low-Intensity versus Conventional-Intensity Warfarin for Prevention of Recurrent Venous Thromboembolism.
349:2164-2167.
2003
-
Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism - The authors reply.
349:2166-2167.
2003
-
Long-term anticoagulant therapy - Reply.
349:1976-1977.
2003
-
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both.
349:1893-1906.
2003
-
Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran.
349:1713-1721.
2003
-
Glutathione Peroxidase 1 Activity and Cardiovascular Events in Patients with Coronary Artery Disease.
349:1605-1613.
2003
-
A Longitudinal, Population-Based, Cohort Study of Childhood Asthma Followed to Adulthood.
349:1414-1422.
2003
-
First-Trimester Screening for Trisomies 21 and 18.
349:1405-1413.
2003
-
Dalteparin Compared with an Oral Anticoagulant for Thromboprophylaxis in Patients with Cancer.
349:1385-1387.
2003
-
Dalteparin compared with an oral anticoagulant for thromboprophylaxis in patients with cancer - The authors reply.
349:1386-1386.
2003
-
A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome.
349:1133-1138.
2003
-
Withdrawal of Mechanical Ventilation in Anticipation of Death in the Intensive Care Unit.
349:1123-1132.
2003
-
Care of Patients Receiving Long-Term Anticoagulant Therapy.
349:675-683.
2003
-
Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism.
349:631-639.
2003
-
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer.
349:247-257.
2003
-
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer.
349:146-153.
2003
-
Off-Pump Coronary Bypass Surgery.
348:1928-1931.
2003
-
Off-pump coronary bypass surgery.
348:1929-1930.
2003
-
Delayed-Onset Heparin-Induced Thrombocytopenia and Cerebral Thrombosis after a Single Administration of Unfractionated Heparin.
348:1067-1069.
2003
-
One-Year Outcomes in Survivors of the Acute Respiratory Distress Syndrome.
348:683-693.
2003
-
Gastrointestinal Angiodysplasia and Aortic Stenosis.
347:858-859.
2002
-
Out of Africa.
347:749-753.
2002
-
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin.
346:1589-1590.
2002
-
Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.
346:1589-1589.
2002
-
Radiotherapy for Breast Cancer.
346:862-864.
2002
-
Radiotherapy for breast cancer..
346:862-864.
2002
-
Treatment of Acute Coronary Syndromes.
346:206-208.
2002
-
Treatment of acute coronary syndromes - Reply.
346:207-208.
2002
-
The Effect of Group Psychosocial Support on Survival in Metastatic Breast Cancer.
345:1719-1726.
2001
-
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation.
345:1716-1716.
2001
-
Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee Surgery.
345:1305-1310.
2001
-
Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture Surgery.
345:1298-1304.
2001
-
Transesophageal Echocardiography to Guide Cardioversion in Patients with Atrial Fibrillation.
345:837-839.
2001
-
Transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation..
345:837.
2001
-
Heparin-Induced Thrombocytopenia.
345:619-620.
2001
-
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation.
345:494-502.
2001
-
Cerebral Sinovenous Thrombosis in Children.
345:417-423.
2001
-
A Synthetic Pentasaccharide for the Prevention of Deep-Vein Thrombosis.
345:291-292.
2001
-
A synthetic pentasaccharide for the prevention of deep-vein thrombosis - Reply.
345:292-292.
2001
-
Prophylactic Mastectomy for Women withBRCA1andBRCA2Mutations — Facts and Controversy.
345:207-208.
2001
-
Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis.
345:165-169.
2001
-
Long-Term Effects of Indomethacin Prophylaxis in Extremely-Low-Birth-Weight Infants.
344:1966-1972.
2001
-
Temporal Aspects of Heparin-Induced Thrombocytopenia.
344:1286-1292.
2001
-
A Synthetic Pentasaccharide for the Prevention of Deep-Vein Thrombosis after Total Hip Replacement.
344:619-625.
2001
-
Safety of Withholding Heparin in Pregnant Women with a History of Venous Thromboembolism.
343:1439-1444.
2000
-
Venous Thromboembolism and Cancer.
343:1337-1338.
2000
-
Venous thromboembolism and cancer. Reply.
343:1338-1338.
2000
-
Alendronate for the Treatment of Osteoporosis in Men.
343:604-610.
2000
-
Exercise Limitation in Health and Disease.
343:632-641.
2000
-
Mechanisms of disease: Exercise limitation in health and disease.
343:632-641.
2000
-
Effect of Ramipril on Cardiovascular Events in High-Risk Patients.
343:64-66.
2000
-
Effect of ramipril on cardiovascular events in high-risk patients. Reply.
343:66-66.
2000
-
Incidence of Cancer after Prophylaxis with Warfarin against Recurrent Venous Thromboembolism.
342:1953-1958.
2000
-
Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients.
342:1917-1918.
2000
-
Effects of Physiologic Pacing versus Ventricular Pacing on the Risk of Stroke and Death Due to Cardiovascular Causes.
342:1385-1391.
2000
-
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients.
342:145-153.
2000
-
Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients.
342:154-160.
2000
-
Alloimmune Thrombocytopenia after Organ Transplantation.
341:1504-1507.
1999
-
Exercise Intolerance Due to Mutations in the CytochromebGene of Mitochondrial DNA.
341:1037-1044.
1999
-
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients.
341:793-800.
1999
-
Carotid Endarterectomy.
340:1209-1212.
1999
-
Carotid endarterectomy.
340:1211-1211.
1999
-
A Comparison of Three Months of Anticoagulation with Extended Anticoagulation for a First Episode of Idiopathic Venous Thromboembolism.
340:901-907.
1999
-
Chiropractic Manipulation for Childhood Asthma.
340:391-392.
1999
-
Chiropractic manipulation for childhood asthma.
340:392-392.
1999
-
Treatment of Asthma with Drugs Modifying the Leukotriene Pathway.
340:197-206.
1999
-
Benefit of Carotid Endarterectomy in Patients with Symptomatic Moderate or Severe Stenosis.
339:1415-1425.
1998
-
A Comparison of Active and Simulated Chiropractic Manipulation as Adjunctive Treatment for Childhood Asthma.
339:1013-1020.
1998
-
Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.
339:292-299.
1998
-
Therapies for ulcers associated with nonsteroidal antiinflammatory drugs..
339:350-351.
1998
-
Prevention of Gastrointestinal Bleeding during Mechanical Ventilation.
339:266-268.
1998
-
Prevention of gastrointestinal bleeding during mechanical ventilation - Reply.
339:267-268.
1998
-
Protective Ventilation for the Acute Respiratory Distress Syndrome.
339:196-199.
1998
-
Protective ventilation for the acute respiratory distress syndrome - Reply.
339:199-199.
1998
-
Enoxaparin plus Compression Stockings Compared with Compression Stockings Alone in the Prevention of Venous Thromboembolism after Elective Neurosurgery.
339:80-85.
1998
-
Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction.
338:1488-1497.
1998
-
CDKN2AMutations in Multiple Primary Melanomas.
338:879-887.
1998
-
A Comparison of Sucralfate and Ranitidine for the Prevention of Upper Gastrointestinal Bleeding in Patients Requiring Mechanical Ventilation.
338:791-797.
1998
-
Low-Molecular-Weight Heparins.
338:687-688.
1998
-
Low-molecular-weight heparins - reply.
338:687-688.
1998
-
Treatment of Men with Paraphilia.
338:464-465.
1998
-
Evaluation of a Ventilation Strategy to Prevent Barotrauma in Patients at High Risk for Acute Respiratory Distress Syndrome.
338:355-361.
1998
-
Low-Molecular-Weight Heparin versus Unfractionated Heparin for Unstable Coronary Disease.
338:129-131.
1998
-
Intermittent Etidronate and Corticosteroid-Induced Osteoporosis.
337:1921-1921.
1997
-
A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias.
337:1576-1584.
1997
-
Low-molecular-weight heparins (vol 337, pg 688, 1997).
337:1567-1567.
1997
-
Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma.
337:1405-1411.
1997
-
High-Dose Intravenous Immune Globulin and the Response to Splenectomy in Patients with Idiopathic Thrombocytopenic Purpura.
337:1087-1089.
1997
-
High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura - Reply.
337:1089-1089.
1997
-
Low-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism.
337:657-662.
1997
-
Low-Molecular-Weight Heparins.
337:688-698.
1997
-
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease.
337:447-452.
1997
-
Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure (vol 336, pg 597, 1997).
337:434-434.
1997
-
Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced Osteoporosis.
337:382-388.
1997
-
Laparoscopic Surgery in Infertile Women with Minimal or Mild Endometriosis.
337:217-222.
1997
-
Digoxin in Patients with Heart Failure.
337:129-131.
1997
-
Digoxin in patients with heart failure - Reply.
337:130-131.
1997
-
Venous thromboembolism - Reply.
337:52-53.
1997
-
High-Dose Intravenous Immune Globulin and the Response to Splenectomy in Patients with Idiopathic Thrombocytopenic Purpura.
336:1494-1498.
1997
-
Management of Anticoagulation before and after Elective Surgery.
336:1506-1511.
1997
-
Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery.
336:1452-1454.
1997
-
Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery..
336:1452.
1997
-
Prevalence and Genotypes of α- and β-Thalassemia Carriers in Hong Kong — Implications for Population Screening.
336:1298-1301.
1997
-
Inhaled Nitric Oxide in Full-Term and Nearly Full-Term Infants with Hypoxic Respiratory Failure.
336:597-604.
1997
-
The Effect of Digoxin on Mortality and Morbidity in Patients with Heart Failure.
336:525-533.
1997
-
The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism.
336:393-398.
1997
-
Inhaled β2-Agonists in the Treatment of Asthma.
335:886-888.
1996
-
Unfractionated versus Low-Molecular-Weight Heparin for Deep Venous Thrombosis.
335:670-672.
1996
-
Unfractionated versus low-molecular-weight heparin for deep venous thrombosis - Reply.
335:671-672.
1996
-
Myocardial Ischemia Detected by Ambulatory Monitoring after Myocardial Infarction.
334:1545-1546.
1996
-
Induction of Labor Compared with Expectant Management for Prelabor Rupture of the Membranes at Term.
334:1005-1010.
1996
-
Community-Acquired Pneumonia.
334:861-863.
1996
-
A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis.
334:677-681.
1996
-
Prognostic Importance of Myocardial Ischemia Detected by Ambulatory Monitoring Early after Acute Myocardial Infarction.
334:65-71.
1996
-
Effects of Radiotherapy and Surgery in Early Breast Cancer — An Overview of the Randomized Trials.
333:1444-1456.
1995
-
DURATION OF ANTICOAGULANT-THERAPY FOR VENOUS THROMBOSIS - REPLY.
333:1289-1289.
1995
-
DURATION OF ANTICOAGULANT-THERAPY FOR VENOUS THROMBOSIS - REPLY.
333:1289-1289.
1995
-
Duration of Anticoagulant Therapy for Venous Thrombosis.
333:1288-1289.
1995
-
FLUOXETINE FOR PREMENSTRUAL DYSPHORIA - REPLY.
333:1153-1153.
1995
-
DISCONTINUATION OF ANTIHYPERLIPIDEMIC DRUGS.
333:1082-1083.
1995
-
Heparin-Induced Thrombocytopenia.
333:1006-1007.
1995
-
A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous Thromboembolism.
332:1661-1665.
1995
-
The Optimal Duration of Anticoagulant Therapy for Venous Thrombosis.
332:1710-1712.
1995
-
Fluoxetine in the Treatment of Premenstrual Dysphoria.
332:1529-1534.
1995
-
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin.
332:1330-1336.
1995
-
Regulating Physician-Assisted Death.
331:1656-1658.
1994
-
Oral Budesonide for Active Crohn's Disease.
331:836-841.
1994
-
The Role of the Plasma from Platelet Concentrates in Transfusion Reactions.
331:625-628.
1994
-
Reproductive Technology -- The Price of Progress.
331:270-271.
1994
-
GASTROINTESTINAL-BLEEDING IN CRITICALLY ILL PATIENTS - REPLY.
331:52-53.
1994
-
Gastrointestinal Bleeding in Critically Ill Patients.
331:51-53.
1994
-
FETAL AND MATERNAL THROMBOCYTOPENIA - REPLY.
330:941-941.
1994
-
Fetal and Maternal Thrombocytopenia.
330:940-941.
1994
-
Low-Molecular-Weight Heparin vs. Warfarin for Prophylaxis against Deep-Vein Thrombosis.
330:862-863.
1994
-
WARFARIN AND ASPIRIN AFTER HEART-VALVE REPLACEMENT - REPLY.
330:508-509.
1994
-
Warfarin and Aspirin after Heart-Valve Replacement.
330:507-509.
1994
-
Risk Factors for Gastrointestinal Bleeding in Critically Ill Patients.
330:377-381.
1994
-
Escalated as Compared with Standard Doses of Doxorubicin in BACOP Therapy for Patients with Non-Hodgkin's Lymphoma.
329:1770-1776.
1993
-
The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial Infarction.
329:1615-1622.
1993
-
Fetal Thrombocytopenia and Its Relation to Maternal Thrombocytopenia.
329:1463-1466.
1993
-
A Comparison of Real-Time Compression Ultrasonography with Impedance Plethysmography for the Diagnosis of Deep-Vein Thrombosis in Symptomatic Outpatients.
329:1365-1369.
1993
-
A Comparison of Subcutaneous Low-Molecular-Weight Heparin with Warfarin Sodium for Prophylaxis against Deep-Vein Thrombosis after Hip or Knee Implantation.
329:1370-1376.
1993
-
An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction.
329:673-682.
1993
-
Treatment for Life-Threatening Illness.
329:736-736.
1993
-
A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement.
329:524-529.
1993
-
Early detection of HIV in neonates..
329:61.
1993
-
Smoking and Radiation Therapy for Head and Neck Cancer.
328:1784-1785.
1993
-
Plasma Triglyceride Level and Mortality from Coronary Heart Disease.
328:1220-1225.
1993
-
Influence of Cigarette Smoking on the Efficacy of Radiation Therapy in Head and Neck Cancer.
328:159-163.
1993
-
Health Care in Canada.
327:1603-1603.
1992
-
Risk Factors for Fatal Residential Fires.
327:859-863.
1992
-
Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions.
327:685-691.
1992
-
Treatment of Preterm Labor with the Beta-Adrenergic Agonist Ritodrine.
327:308-312.
1992
-
β-Agonists and Death from Asthma.
327:354-357.
1992
-
Induction of Labor as Compared with Serial Antenatal Monitoring in Post-Term Pregnancy.
326:1587-1592.
1992
-
CAROTID ENDARTERECTOMY - REPLY.
326:764-764.
1992
-
Carotid Endarterectomy.
326:762-765.
1992
-
ORAL ANTICOAGULANT DRUGS - REPLY.
326:68-69.
1992
-
HEPARIN - REPLY.
325:1585-1586.
1991
-
INDEXES PREDICTIVE OF WEANING FROM MECHANICAL VENTILATION.
325:1443-1443.
1991
-
Indexes Predictive of Weaning from Mechanical Ventilation.
325:1442-1444.
1991
-
Relation between Airway Responsiveness and Serum IgE in Children with Asthma and in Apparently Normal Children.
325:1067-1071.
1991
-
Hydroxychloroquine in Systemic Lupus Erythematosus.
325:1046-1046.
1991
-
Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis.
325:445-453.
1991
-
Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic Purpura.
325:393-397.
1991
-
Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure.
325:293-302.
1991
-
Sex Differences in Neuroanatomical Changes with Aging.
325:211-212.
1991
-
DRUG-THERAPY - ORAL ANTICOAGULANT DRUGS.
324:1865-1875.
1991
-
Oral Anticoagulant Drugs.
324:1865-1875.
1991
-
Heparin.
324:1565-1574.
1991
-
Inhibition of Exercise-Induced Bronchoconstriction by MK-571, a Potent Leukotriene D4–Receptor Antagonist.
324:1288-1288.
1991
-
A Randomized Study of the Effect of Withdrawing Hydroxychloroquine Sulfate in Systemic Lupus Erythematosus.
324:150-154.
1991
-
Inhibition of Exercise-Induced Bronchoconstriction by MK-571, a Potent Leukotriene D4–Receptor Antagonist.
323:1736-1739.
1990
-
COMPETENT PATIENTS AND IRRATIONAL CHOICES.
323:1354-1354.
1990
-
The Diagnosis and Prognosis of Autosomal Dominant Polycystic Kidney Disease.
323:1085-1090.
1990
-
Effect of Age at the Start of Iron Chelation Therapy on Gonadal Function in β-Thalassemia Major.
323:713-719.
1990
-
Hemoglobin Bart's Disease in an Italian Boy.
323:179-182.
1990
-
High Blood Alcohol Levels in Women.
323:58-62.
1990
-
The Canadian Health Care System.
322:1675-1676.
1990
-
The Canadian health care system. Medical Reform Group of Ontario..
322:1675-1676.
1990
-
Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous Thrombosis.
322:1260-1264.
1990
-
HEPARIN FOR MURAL THROMBOSIS IN ANTERIOR MYOCARDIAL-INFARCTION - REPLY.
321:260-260.
1989
-
Heparin for Mural Thrombosis in Anterior Myocardial Infarction.
321:259-260.
1989
-
Urinary Incontinence among Elderly Persons.
320:1421-1422.
1989
-
Controlling Health Expenditures — the Canadian Reality.
320:571-577.
1989
-
Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial Infarction.
320:352-357.
1989
-
THROMBOCYTOPENIA DURING PREGNANCY - REPLY.
319:1483-1483.
1988
-
Thrombocytopenia during Pregnancy.
319:1482-1483.
1988
-
Adjuvant Therapy for Breast Cancer.
319:443-446.
1988
-
Incidentally Detected Thrombocytopenia in Healthy Mothers and Their Infants.
319:142-145.
1988
-
An Assessment of Clinically Useful Measures of the Consequences of Treatment.
318:1728-1733.
1988
-
Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparin.
318:1162-1173.
1988
-
PLASMA GLYCOCALICIN - REPLY.
318:1071-1071.
1988
-
Plasma Glycocalicin.
318:1070-1071.
1988
-
CREUTZFELDT-JAKOB DISEASE IN HISTOPATHOLOGY TECHNICIANS.
318:854-854.
1988
-
The Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast Cancer.
318:404-407.
1988
-
Partial Ankyrin and Spectrin Deficiency in Severe, Atypical Hereditary Spherocytosis.
318:230-234.
1988
-
Plasma Glycocalicin.
317:1037-1042.
1987
-
THE EC-IC BYPASS STUDY - REPLY.
317:1031-1032.
1987
-
The EC-IC Bypass Study.
317:1030-1032.
1987
-
HEPARIN FOR PROXIMAL-VEIN THROMBOSIS - REPLY.
316:1162-1163.
1987
-
Heparin for Proximal-Vein Thrombosis.
316:1161-1163.
1987
-
Low-Molecular-Weight Heparin and Deep-Vein Thrombosis.
316:949-949.
1987
-
ARE THE RESULTS OF THE EXTRACRANIAL INTRACRANIAL BYPASS TRIAL GENERALIZABLE.
316:817-824.
1987
-
Are the Results of the Extracranial–Intracranial Bypass Trial Generalizable?.
316:820-824.
1987
-
Early Detection of HIV Infection in a Newborn.
316:272-273.
1987
-
Are Humans a Source ofEscherichia coli0157:H7, the Agent of Hemorrhagic Colitis?.
315:1612-1613.
1986
-
Immunosuppressive Factor (or Factors) Produced by Human Embryos in Vitro.
315:1551-1552.
1986
-
THERAPY OF HYPONATREMIA.
315:1353-1353.
1986
-
Therapy of Hyponatremia.
315:1351-1355.
1986
-
Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein Thrombosis.
315:1109-1114.
1986
-
Fatal Asthma in New Zealand.
315:1029-1029.
1986
-
A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip Surgery.
315:925-929.
1986
-
Control of Asthma by Aerosols.
315:870-874.
1986
-
Determining Optimal Therapy — Randomized Trials in Individual Patients.
315:767-768.
1986
-
Airway Responsiveness to Leukotrienes C4 and D4 and to Methacholine in Patients with Asthma and Normal Controls.
315:480-484.
1986
-
EXTRACRANIAL-INTRACRANIAL ARTERIAL BYPASS - REPLY.
314:1193-1193.
1986
-
Extracranial–Intracranial Arterial Bypass.
314:1192-1193.
1986
-
Determining Optimal Therapy — Randomized Trials in Individual Patients.
314:889-892.
1986
-
METHYLDOPA AND RETICULOENDOTHELIAL FUNCTION - REPLY.
314:249-249.
1986
-
Methyldopa and Reticuloendothelial Function.
314:248-249.
1986
-
Embryonic ζ-Globin Chains in Adults: a Marker for α-Thalassemia-1 Haplotype Due to a >17.5-kb Deletion.
314:76-79.
1986
-
Fatal asthma in New Zealand.
315:1929.
1986
-
Aspirin, Sulfinpyrazone, or Both in Unstable Angina.
313:1369-1375.
1985
-
Impaired Reticuloendothelial Function in Patients Treated with Methyldopa.
313:596-600.
1985
-
Untreated Low-Grade Non-Hodgkin's Lymphoma.
312:1191-1192.
1985
-
Ketoconazole in the Management of Precocious Puberty Not Responsive to LHRH-Analogue Therapy.
312:1023-1028.
1985
-
Coronary Atheroembolism.
310:722-722.
1984
-
PREGNANCY IN INFERTILE COUPLES - REPLY.
310:1335-1335.
1984
-
Labeling of Hypertensive Patients.
309:1253-1253.
1983
-
Treatment-Independent Pregnancy among Infertile Couples.
309:1201-1206.
1983
-
Intensive Care of Low-Birth-Weight Infants.
309:1058-1060.
1983
-
Economic Evaluation of Neonatal Intensive Care of Very-Low-Birth-Weight Infants.
308:1330-1337.
1983
-
A Medical-School Curriculum for the 1980s.
308:1230-1232.
1983
-
Intravenous Streptokinase for Acute Myocardial Infarction.
308:592-594.
1983
-
INTENSIVE-CARE OF LOW-BIRTH-WEIGHT INFANTS - REPLY.
309:1060-1060.
1983
-
INTRAVENOUS STREPTOKINASE FOR ACUTE MYOCARDIAL-INFARCTION - REPLY.
308:593-594.
1983
-
Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis.
307:1676-1681.
1982
-
Effect of Intravenous Streptokinase on Acute Myocardial Infarction.
307:1180-1182.
1982
-
Subcutaneous Heparin for Venous Thrombosis.
307:56-58.
1982
-
Adjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-Term Treatment of Venous Thrombosis.
306:189-194.
1982
-
ECHOCARDIOGRAPHIC ESTIMATES OF PULMONARY-ARTERY WEDGE PRESSURE.
307:188-188.
1982
-
SUBCUTANEOUS HEPARIN FOR VENOUS THROMBOSIS - REPLY.
307:57-58.
1982
-
Urolithiasis Due to 2,8-Dihydroxyadenine in an Adult.
305:1570-1572.
1981
-
Proteinuria in Hashimoto's Thyroiditis.
305:1286-1286.
1981
-
Evaluation of Neonatal-Intensive-Care Programs.
305:489-494.
1981
-
Cost Effectiveness of Clinical Diagnosis, Venography, and Noninvasive Testing in Patients with Symptomatic Deep-Vein Thrombosis.
304:1561-1567.
1981
-
The Leboyer Method of Childbirth.
303:640-641.
1980
-
Neonatal Thrombocytopenia Due to Passive Immunization.
302:1401-1403.
1980
-
In Vitro Study of Drug-Induced Granulocytopenia.
302:1151-1151.
1980
-
Sleep Hypoxemia at High Altitude.
302:813-814.
1980
-
Prevention of Recurrent Venous Thrombosis: Warfarin versus Heparin.
302:752-753.
1980
-
A Randomized Clinical Trial of the Leboyer Approach to Childbirth.
302:655-660.
1980
-
Expressions of Probability: Words and Numbers.
302:411-411.
1980
-
PREVENTION OF RECURRENT VENOUS THROMBOSIS - WARFARIN VERSUS HEPARIN - REPLY.
302:753-753.
1980
-
SLEEP HYPOXEMIA AT HIGH-ALTITUDE - REPLY.
302:814-814.
1980
-
THE LEBOYER METHOD OF CHILDBIRTH - REPLY.
303:641-641.
1980
-
Effect of Acetazolamide on Hypoxemia during Sleep at High Altitude.
301:1329-1331.
1979
-
Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis.
301:855-858.
1979
-
The Use of in Vitro Technics to Study Drug-Induced Pancytopenia.
301:621-624.
1979
-
Leprosy's Footprints in Bone Marrow.
301:272-273.
1979
-
Platelet-Associated IgG in Septicemia.
301:271-272.
1979
-
Elevated Platelet-Associated IgG in the Thrombocytopenia of Septicemia.
300:760-764.
1979
-
Increased Absenteeism after Diagnosis of Hypertension.
300:318-319.
1979
-
Increased Absenteeism from Work after Detection and Labeling of Hypertensive Patients.
299:741-744.
1978
-
Red-Cell Stability in Duchenne's Syndrome.
298:403-403.
1978
-
Combined Use of Leg Scanning and Impedance Plethysmography in Suspected Venous Thrombosis.
296:1497-1500.
1977
-
Identification of GABA in Human CSF by Gas Liquid Chromatography and Mass Spectrometry.
296:692-692.
1977
-
Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease.
293:1296-1300.
1975
-
Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease.
293:1236-1240.
1975
-
Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease.
293:1174-1178.
1975
-
New Tests to Assess Lung Function.
293:647-650.
1975
-
New Tests to Assess Lung Function.
293:541-544.
1975
-
The Occupation of Fishing as a Risk Factor in Cancer of the Lip.
293:419-424.
1975
-
End-Expiratory Pressure and Oxygen Transport.
292:1130-1132.
1975
-
Use of Hypnotics.
292:217-218.
1975
-
Arteriovenous-Shunt Thrombosis.
290:304-306.
1974
-
The Burlington Randomized Trial of the Nurse Practitioner.
290:251-256.
1974
-
Neuropathy in McArdle's Syndrome.
289:750-751.
1973
-
Neuropathy in Thyrotoxicosis.
289:219-220.
1973
-
Red-cell 2,3-diphosphoglycerate in children..
288:1026.
1973
-
Pulsus Paradoxus and Airways Obstruction.
288:793-794.
1973
-
Small Subcutaneous Doses of Heparin in Prevention of Venous Thrombosis.
288:545-551.
1973
-
The Anemia of Childhood.
288:388-392.
1973
-
A Prospective Study of the Value of Monitoring Heparin Treatment with the Activated Partial Thromboplastin Time.
287:324-327.
1972
-
Chinese-Restaurant Syndrome, Recurrence.
286:893-894.
1972
-
Vasopressin Inhibition by Lithium.
284:674-675.
1971
-
Microangiopathic Hemolytic Anemia.
281:833-835.
1969
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)